Login to Your Account

U.S. Patent Disclosures

Friday, July 15, 2011
Lpath Inc., of San Diego, received U.S. Patent No. 7,956,173, which covers composition of matter related to sonepcizumab, the drug substance in the firm's lead compounds, iSONEP and ASONEP

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription